InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Bigalke John T., Director. Officer active across 2 companies, notably PROGENITY, INC.. Aggregated, 9 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €43k. History available since 14 June 2021. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
1,137 shares@ US$17.5443.9% of flowClass A Common StockSEC:0000950170-25-034253:0
7,101 shares0Class A Common StockSEC:0000950170-24-134876:0
1,136 shares@ US$22.1956.1% of flowClass A Common StockSEC:0000950170-24-134136:0
7,333 shares0Class A Common StockSEC:0001209191-23-057472:0
4,636 shares0Class A Common StockSEC:0001209191-22-060178:0
4,098 shares0Class A Common StockSEC:0001209191-21-068238
4,098 shares0Class A Common StockSEC:0001209191-21-068238:0
29,183 shares0Common StockSEC:0000899243-21-024205
29,183 shares0Common StockSEC:0000899243-21-024205:0
9 of 9 declarations
About Bigalke John T.
John T. Bigalke is a Board Member at Progenity, Inc. and Premier, Inc. He brings valuable expertise in the life sciences and technology fields. As a board member, he is involved in overseeing operations and making strategic decisions to support innovation and research. His experience in the sector is a significant asset to the companies.
